20VC: $5BN in Revenue, 7 to 7,000 Employees in 9 Months, 206,000 Tests in a Single Day: The Craziest Story in Startups: Curative with Fred Turner

Fred Turner, CEO of Curative, details his transition from cattle genomics to scaling a multi-billion dollar COVID-19 testing enterprise, and his subsequent pivot into the health insurance market. The conversation highlights the operational necessity of building "orthogonal supply chains" during the pandemic and the shift toward an agentic, AI-driven business model. Turner explains how internal AI agents now handle complex tasks like credentialing and contract negotiations, significantly reducing costs and headcount. Beyond healthcare, he discusses his venture into nuclear fission with Subcritical, emphasizing that the primary barrier to nuclear energy is regulatory rather than technological. Throughout the discussion, Turner advocates for leveraging AI to replace manual back-office labor, arguing that these efficiencies allow companies to scale volume exponentially while maintaining a lean, high-output workforce.